The initial success of Viagra undeniably revolutionized the drug landscape, but investing in companies heavily reliant on unbranded versions presents a complex picture. Despite early profits were significant, the expiration of patents and the appearance of less expensive alternatives have diminished sales. Consequently, a thorough analysis of ongoi